{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T11:19:11Z","timestamp":1707736751669},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00228-016-2041-1","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T01:44:06Z","timestamp":1458524646000},"page":"813-822","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study"],"prefix":"10.1007","volume":"72","author":[{"given":"Katja","family":"Cvan Trobec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iztok","family":"Grabnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojca","family":"Kerec Kos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomaz","family":"Vovk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurij","family":"Trontelj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitja","family":"Lainscak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"2041_CR1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, ESC Committee for Practice Guidelines et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 14:803\u2013869","journal-title":"Eur J Heart Fail"},{"key":"2041_CR2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0195-668X(02)00743-1","volume":"24","author":"T Simon","year":"2003","unstructured":"Simon T, Mary-Krause M, Funck-Brentano C, Lechat P, Jaillon P (2003) Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study (CIBIS II). Eur Heart J 24:552\u2013559","journal-title":"Eur Heart J"},{"key":"2041_CR3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0002-9343(02)01346-3","volume":"113","author":"DD Sin","year":"2002","unstructured":"Sin DD, McAlister FA (2002) The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. Am J Med 113:650\u2013656","journal-title":"Am J Med"},{"key":"2041_CR4","doi-asserted-by":"crossref","first-page":"f55","DOI":"10.1136\/bmj.f55","volume":"346","author":"S Chatterjee","year":"2013","unstructured":"Chatterjee S, Biondi-Zoccai G, Abbate A, D\u2019Ascenzo F, Castagno D, Van Tassell B, Mukherjee D, Lichstein E (2013) Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ 346:f55","journal-title":"BMJ"},{"key":"2041_CR5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0009-9236(03)00169-3","volume":"74","author":"H Kraiczi","year":"2003","unstructured":"Kraiczi H, Jang T, Ludden T, Peck CC (2003) Randomized concentration-controlled trials: motivations, use, and limitations. Clin Pharmacol Ther 74:203\u2013214","journal-title":"Clin Pharmacol Ther"},{"key":"2041_CR6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2165\/00003088-199426040-00005","volume":"26","author":"DJ Morgan","year":"1994","unstructured":"Morgan DJ, Bray KM (1994) Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet 26:292\u2013307","journal-title":"Clin Pharmacokinet"},{"key":"2041_CR7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12020-012-9836-3","volume":"43","author":"HM Christensen","year":"2013","unstructured":"Christensen HM, Kistorp C, Schou M, Keller N, Zerahn B, Frystyk J, Schwarz P, Faber J (2013) Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status. Endocrine 43:626\u2013634","journal-title":"Endocrine"},{"key":"2041_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.metabol.2013.09.017","volume":"63","author":"HM Christensen","year":"2014","unstructured":"Christensen HM, Kistorp C, Schou M, Keller N, Zerahn B, Frystyk J, Flyvbjerg A, Faber J (2014) Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study. Metabolism 63:141\u2013149","journal-title":"Metabolism"},{"key":"2041_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","volume":"1","author":"S Haehling Von","year":"2010","unstructured":"Von Haehling S, Anker SD (2010) Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle 1:1\u20135","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2041_CR10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079603","volume":"8","author":"K Trobec","year":"2013","unstructured":"Trobec K, Kerec Kos M, von Haehling S, Springer J, Anker SD, Lainscak M (2013) Pharmacokinetics of drugs in cachectic patients: a systematic review. PLoS One 8, e79603","journal-title":"PLoS One"},{"key":"2041_CR11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Anker SD, Dahlstr\u00f6m U, Heart Failure Association of the ESC et al (2013) Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC heart failure long-term registry. Eur J Heart Fail 15:1173\u20131184","journal-title":"Eur J Heart Fail"},{"key":"2041_CR12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2165\/00003088-198713020-00003","volume":"13","author":"W Kirch","year":"1987","unstructured":"Kirch W, Rose I, Demers HG, Leopold G, Pabst J, Ohnhaus EE (1987) Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease. Clin Pharmacokinet 13:110\u2013117","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl M","key":"2041_CR13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/eurheartj\/8.suppl_M.15","volume":"8","author":"CD Payton","year":"1987","unstructured":"Payton CD, Fox JG, Pauleau NF, Boulton-Jones JM, Ioannides C, Johnston A, Thomas P (1987) The single dose pharmacokinetics of bisoprolol (10\u00a0mg) in renal insufficiency: the clinical significance of balanced clearance. Eur Heart J 8(Suppl M):15\u201322","journal-title":"Eur Heart J"},{"key":"2041_CR14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/j.1552-4604.1986.tb02959.x","volume":"26","author":"G Leopold","year":"1986","unstructured":"Leopold G, Pabst J, Ungeth\u00fcm W, B\u00fchring KU (1986) Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist. J Clin Pharmacol 26:616\u2013621","journal-title":"J Clin Pharmacol"},{"key":"2041_CR15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00265912","volume":"41","author":"C Jeunne Le","year":"1991","unstructured":"Le Jeunne C, Poirier JM, Cheymol G, Ertzbischoff O, Engel F, Hugues FC (1991) Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers. Eur J Clin Pharmacol 41:171\u2013174","journal-title":"Eur J Clin Pharmacol"},{"key":"2041_CR16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/aje\/kwh058","volume":"159","author":"I Janssen","year":"2004","unstructured":"Janssen I (2004) Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 159:413\u2013421","journal-title":"Am J Epidemiol"},{"key":"2041_CR17","first-page":"303","volume":"5","author":"D Bois Du","year":"1989","unstructured":"Du Bois D, Du Bois EF (1989) A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5:303\u2013311, discussion 312-3","journal-title":"Nutrition"},{"key":"2041_CR18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argil\u00e9s J et al (2008) Cachexia: a new definition. Clin Nutr 27:793\u2013799","journal-title":"Clin Nutr"},{"key":"2041_CR19","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/ajcn\/82.5.1074","volume":"82","author":"MM Wilson","year":"2005","unstructured":"Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A, Diebold MR, Morley JE (2005) Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr 82:1074\u20131081","journal-title":"Am J Clin Nutr"},{"key":"2041_CR20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.clnu.2008.04.004","volume":"27","author":"MM Schl\u00fcssel","year":"2008","unstructured":"Schl\u00fcssel MM, dos Anjos LA, de Vasconcellos MTL, Kac G (2008) Reference values of handgrip dynamometry of healthy adults: a population-based study. Clin Nutr 27:601\u2013607","journal-title":"Clin Nutr"},{"key":"2041_CR21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1681\/ASN.V62257","volume":"6","author":"F Gaspari","year":"1995","unstructured":"Gaspari F, Perico N, Ruggenenti P, Mosconi L, Amuchastegui CS, Guerini E, Daina E, Remuzzi G (1995) Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 6:257\u2013263","journal-title":"J Am Soc Nephrol"},{"key":"2041_CR22","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1023\/A:1011970125687","volume":"15","author":"EN Jonsson","year":"1998","unstructured":"Jonsson EN, Karlsson MO (1998) Automated covariate model building within NONMEM. Pharm Res 15:1463\u20131468","journal-title":"Pharm Res"},{"key":"2041_CR23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.clpt.6100241","volume":"82","author":"MO Karlsson","year":"2007","unstructured":"Karlsson MO, Savic RM (2007) Diagnosing model diagnostics. Clin Pharmacol Ther 82:17\u201320","journal-title":"Clin Pharmacol Ther"},{"key":"2041_CR24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1208\/s12248-009-9133-0","volume":"11","author":"RM Savic","year":"2009","unstructured":"Savic RM, Karlsson MO (2009) Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions. AAPS J 11:558\u2013569","journal-title":"AAPS J"},{"key":"2041_CR25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO (2011) Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J 13:143\u2013151","journal-title":"AAPS J"},{"key":"2041_CR26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00228-012-1427-y","volume":"69","author":"VN Nikolic","year":"2013","unstructured":"Nikolic VN, Jevtovic-Stoimenov T, Velickovic-Radovanovi\u0107 R et al (2013) Population pharmacokinetics of bisoprolol in patients with chronic heart failure. Eur J Clin Pharmacol 69:859\u2013865","journal-title":"Eur J Clin Pharmacol"},{"key":"2041_CR27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3325\/cmj.2015.56.531","volume":"56","author":"K Trobec","year":"2015","unstructured":"Trobec K, Kerec Kos M, Haehling S, Anker SD, Macdougall IC, Ponikowski P, Lain\u0161\u010dak M (2015) Iohexol clearance is superior to creatinine-based renal function estimating equations in detecting short-term renal function decline in chronic heart failure. Croat Med J 56:531\u2013541","journal-title":"Croat Med J"},{"key":"2041_CR28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.HYP.37.2.250","volume":"37","author":"AM Sharma","year":"2001","unstructured":"Sharma AM, Pischon T, Hardt S, Kunz I, Luft FC (2001) Hypothesis: beta-adrenergic receptor blockers and weight gain: a systematic analysis. Hypertension 37:250\u2013254","journal-title":"Hypertension"},{"key":"2041_CR29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cardfail.2011.10.016","volume":"18","author":"BWJ Boxall","year":"2012","unstructured":"Boxall BWJ, Clark AL (2012) Beta-blockers and weight change in patients with chronic heart failure. J Card Fail 18:233\u2013237","journal-title":"J Card Fail"},{"issue":"Suppl 7","key":"2041_CR30","doi-asserted-by":"crossref","first-page":"433s","DOI":"10.1042\/cs061433s","volume":"61","author":"G Koch","year":"1981","unstructured":"Koch G, Franz IW, Lohmann FW (1981) Effects of short-term and long-term treatment with cardio-selective and non-selective beta-receptor blockade on carbohydrate and lipid metabolism and on plasma catecholamines at rest and during exercise. Clin Sci (London) 61(Suppl 7):433s\u2013435s","journal-title":"Clin Sci (London)"},{"key":"2041_CR31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2005.01.061","volume":"106","author":"M Lainscak","year":"2006","unstructured":"Lainscak M, Keber I, Anker SD (2006) Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study. Int J Cardiol 106:319\u2013322","journal-title":"Int J Cardiol"},{"key":"2041_CR32","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40262-014-0189-3","volume":"53","author":"R Ogawa","year":"2014","unstructured":"Ogawa R, Stachnik JM, Echizen H (2014) Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally). Clin Pharmacokinet 53:1083\u20131114","journal-title":"Clin Pharmacokinet"},{"key":"2041_CR33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijcard.2007.11.103","volume":"125","author":"GP Arutyunov","year":"2008","unstructured":"Arutyunov GP, Kostyukevich OI, Serov RA, Rylova NV, Bylova NA (2008) Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure. Int J Cardiol 125:240\u2013245","journal-title":"Int J Cardiol"},{"key":"2041_CR34","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","volume":"50","author":"A Sandek","year":"2007","unstructured":"Sandek A, Bauditz J, Swidsinski A et al (2007) Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 50:1561\u20131569","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/eurheartj\/eht271","volume":"35","author":"G Rogler","year":"2014","unstructured":"Rogler G, Rosano G (2014) The heart and the gut. Eur Heart J 35:426\u2013430","journal-title":"Eur Heart J"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2041-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-016-2041-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2041-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T18:54:28Z","timestamp":1655319268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-016-2041-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["2041"],"URL":"https:\/\/doi.org\/10.1007\/s00228-016-2041-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}